Literature DB >> 9559044

Ischemic cholangitis.

K P Batts1.   

Abstract

Ischemia-induced bile duct lesions have been collectively labeled as ischemic cholangitis. The biliary epithelium is dependent on arterial blood flow, unlike the hepatic parenchyma with its dual arterial and portal venous blood supply. As such, the biliary epithelium is susceptible to injury when arterial blood flow is compromised. This compromise can occur at the level of the major, named hepatic artery branches or at the microscopic, peribiliary capillary plexus level. Typically, ischemic cholangitis manifests as segmental strictures and cholangiectases with resultant mechanical impairment of bile flow and, occasionally, secondary infection of the biliary system. Ischemic cholangitis after liver transplantation is becoming an important problem and likely is attributable to numerous factors. Hepatic arterial infusion of chemotherapy and systemic vasculitis are other causes of ischemic cholangitis. The role of ischemia in other chronic biliary and ductopenic diseases remains speculative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559044     DOI: 10.1016/S0025-6196(11)63706-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  18 in total

1.  Primary sclerosing cholangitis associated with lupus nephritis: a rare association.

Authors:  Yoshiko Kadokawa; Katsuhisa Omagari; Isao Matsuo; Yoshiko Otsu; Umpei Yamamoto; Tomoya Nishino; Kazuo Ohba; Masanobu Miyazaki; Takashi Harada; Takashi Taguchi; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Portal biliopathy in patients with non-cirrhotic portal hypertension: does the type of surgery affect outcome?

Authors:  Somnath Chattopadhyay; Mahendran Govindasamy; Punit Singla; Vibha Varma; Naimish Mehta; Vinay Kumaran; Samiran Nundy
Journal:  HPB (Oxford)       Date:  2012-05-03       Impact factor: 3.647

Review 3.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

4.  Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis.

Authors:  Alexandre Louvet; Frederic Texier; Sebastien Dharancy; François-Rene Pruvot; Geraldine Sergent; Pierre Deltenre; Olivier Ernst; Jean-Claude Paris; Philippe Mathurin
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

5.  Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysiologic mechanisms.

Authors:  Johannes Benninger; Rainer Grobholz; Yurdaguel Oeztuerk; Christoph H Antoni; Eckhart G Hahn; Manfred V Singer; Richard Strauss
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

6.  Development of an experimental model of cholestasis induced by hypoxic/ischemic damage to the bile duct and liver tissues in infantile rats.

Authors:  Fumiaki Toki; Atsushi Takahashi; Makoto Suzuki; Sayaka Ootake; Junko Hirato; Hiroyuki Kuwano
Journal:  J Gastroenterol       Date:  2011-02-25       Impact factor: 7.527

7.  Portal biliopathy: a study of 39 surgically treated patients.

Authors:  Anil Kumar Agarwal; Dharamanjai Sharma; Shivendra Singh; Shaleen Agarwal; S P Girish
Journal:  HPB (Oxford)       Date:  2011-01       Impact factor: 3.647

8.  Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.

Authors:  Shannon Glaser; Paolo Onori; Eugenio Gaudio; Yoshiyuki Ueno; Luigi Pannarale; Antonio Franchitto; Heather Francis; Romina Mancinelli; Guido Carpino; Julie Venter; Mellanie White; Shelley Kopriva; Antonella Vetuschi; Roberta Sferra; Gianfranco Alpini
Journal:  Dig Liver Dis       Date:  2010-03-20       Impact factor: 4.088

9.  Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: report of a case.

Authors:  Yutaro Kato; Kentaro Matsubara; Yoshinobu Akiyama; Hiroaki Hattori; Akira Hirata; Fumio Suzuki; Hitoshi Ohtaka; Ayu Kato; Yoshiaki Sugiura; Masaki Kitajima
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

Review 10.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.